Open AccessInhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment
Author(s) -
Zaretsky Dmitry V.,
Zaretskaia Maria V.,
Durant Pamela J.,
Rusyniak Daniel E.
Publication year - 2014
Publication title -
pharmacology research and perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.975
H-Index - 27
ISSN - 2052-1707
DOI - 10.1002/prp2.31
Subject(s) - mdma , thermoregulation , hyperthermia , raphe , brown adipose tissue , endocrinology , vasoconstriction , medicine , chemistry , hypothermia , hypothalamus , serotonin , thermogenesis , pharmacology , biology , serotonergic , adipose tissue , receptor
Abstract The central mechanisms through which 3,4‐methylenedioxymethamphetamine ( MDMA ) mediates life‐threatening hyperthermia when taken in a warm environment are not well described. It is assumed that MDMA alters normal thermoregulatory circuits resulting in increased heat production through interscapular brown adipose tissue ( iBAT ) and decreased heat dissipation through cutaneous vasoconstriction. We studied the role of the dorsomedial hypothalamus ( DMH ) and medullary raphe pallidus ( mRPa ) in mediating iBAT , tail blood flow, and locomotor effects produced by MDMA . Rats were instrumented with guide cannulas targeting either the DMH or the mRPa brain regions involved in regulating iBAT and cutaneous vascular beds. In all animals, core temperature and locomotion were recorded with surgically implanted telemetric transmitters; additionally, either iBAT temperature (via telemetric transmitter) or tail artery blood flow (via tail artery D oppler cuff) were also recorded. Animals were placed in an environmental chamber at 32°C and microinjected with either control or the gamma‐aminobutyric acid (GABA) agonist muscimol (80 pmol) followed by an intravenous injection of saline or MDMA (7.5 mg kg −1 ). To prevent undue suffering, a core temperature of 41°C was chosen as the surrogate marker of mortality. Inhibition of the DMH , but not the mRPa , prevented mortality and attenuated hyperthermia and locomotion. Inhibition of either the DMH or the mRP a did not affect iBAT temperature increases or tail blood flow decreases. While MDMA increases iBAT thermogenesis and decreases heat dissipation through cutaneous vasoconstriction, thermoregulatory brain regions known to mediate these effects are not involved. Rather, the finding that inhibiting the DMH decreases both locomotion and body temperature suggests that locomotion may be a key central contributor to MDMA ‐evoked hyperthermia.